NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 4 FDA
NCT01750918 2021-10-29BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)NovartisPhase 1/2 Completed166 enrolled 46 charts